Novartis Consumer Health, Inc. has announced a voluntary recall, along with a temporary shutdown of its Nebraska production facility. The recall relates to the over-the-counter drugs Bufferin, Excedrin, Gas-X Prevention, and NoDoz and results from reports of chipped and broken pills, as well as “inconsistent bottle packaging clearance practices” which can result in bottles being cross-contaminated with foreign tablets or capsules.
The recall was issued to prevent the possibility of a consumer taking incorrect medications, with the potential for overdosing as well as drug-related reactions such as allergies. According to reports, various combinations of oxycodone, acetaminophen, aspirin, and seven other opiate products may have been placed into incorrect packaging. The FDA has warned health care professionals of the potential risks that are related to these incidents.
Pharmaceutical companies engaged in the profitable business of manufacturing and selling drugs are constantly introducing new medications into the marketplace. Each year, thousands of people are injured or killed due to the allegedly dangerous and defective characteristics of such products.
If you or a loved one has been victimized by the ingestion of a dangerous or defective prescription drug and would like to speak with an attorney, please contact us. You can call us at (617) 742-1900, or if you are outside the Boston area, call toll-free at 1-800-545-3732. We are here to answer your questions and discuss how to protect your legal rights.
By James A. Swartz of Swartz & Swartz, P.C. – Permalink